P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents
O'BRIEN, Fionn E, O'CONNOR, Richard M, CLARKE, Gerard, DINAN, Timothy G, GRIFFIN, Brendan T, CRYAN, John F
Published in Neuropsychopharmacology (New York, N.Y.) (01.10.2013)
Published in Neuropsychopharmacology (New York, N.Y.) (01.10.2013)
Get full text
Journal Article
Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood–brain barrier permeability
O'Brien, Fionn E., Clarke, Gerard, Dinan, Timothy G., Cryan, John F., Griffin, Brendan T.
Published in The international journal of neuropsychopharmacology (01.11.2013)
Published in The international journal of neuropsychopharmacology (01.11.2013)
Get full text
Journal Article
The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram
O’Brien, Fionn E., O’Connor, Richard M., Clarke, Gerard, Donovan, Maria D., Dinan, Timothy G., Griffin, Brendan T., Cryan, John F.
Published in Behavioural brain research (15.03.2014)
Published in Behavioural brain research (15.03.2014)
Get full text
Journal Article
The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat
Donovan, Maria D, O'Brien, Fionn E, Boylan, Geraldine B, Cryan, John F, Griffin, Brendan T
Published in Journal of pharmacy and pharmacology (01.04.2015)
Published in Journal of pharmacy and pharmacology (01.04.2015)
Get more information
Journal Article
Chronic P‐glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression
O'Brien, Fionn E., Moloney, Gerard M., Scott, Karen A., O'Connor, Richard M., Clarke, Gerard, Dinan, Timothy G., Griffin, Brendan T., Cryan, John F.
Published in Pharmacology research & perspectives (01.12.2015)
Published in Pharmacology research & perspectives (01.12.2015)
Get full text
Journal Article